A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

据路透社报道，10个月前，布宜诺斯艾利斯（Buenos Aires）的非盈利研究机构Kheiron Biotech培育的五匹经过CRISPR-Cas9技术编辑的马出生了，现在，这些小马驹正在茁壮成长，与它们一道茁壮成长的是阿根廷的马饲养者中对此的争议 ...

CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.

CRISPR Therapeutics (CRSP) just announced that its SyNTase gene editing technology will be featured in an oral presentation at the ESGCT 2025 Congress. This marks the first major public unveiling of ...

This makes the organs virus-free and less likely to trigger an immune response, improving their safety and durability.

The model is built on CRISPR technology, a powerful gene editing tool used to edit genomes and develop therapies for genetic diseases. However, training to use this tool for designing experiments can ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout ...